Non-Current Assets
Goodwill
Insmed Goodwill remained flat by 0.0% to $136.11M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $136.11M to $136.11M.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
A significant increase indicates recent M&A activity, while a sudden decrease typically signals an impairment charge due to underperforming acquisitions.
Detailed definition
Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...
Peer comparison
Standard metric for companies that grow through acquisition; comparable across all industries.
Metric ID:
goodwillHistorical Data
19 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M | $136.11M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$136.11M – $136.11M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak18+ quarters growth
Goodwill at Other Companies
Frequently Asked Questions
- What is Insmed's goodwill?
- Insmed (INSM) reported goodwill of $136.11M in Q1 2026.
- How has Insmed's goodwill changed year-over-year?
- Insmed's goodwill decreased by 0.0% year-over-year, from $136.11M to $136.11M.
- What does goodwill mean?
- The excess price paid for an acquisition over the fair value of its net assets.